Home Applications 217684 Application 217684
Type NDA
Sponsor PYROS PHARMS Application Products# Product, Drug, Ingredient table Product Drug Ingredient Form Strength Reference drug Reference standard 001 VIGAFYDE VIGABATRIN SOLUTION;ORAL 100MG/ML Yes Yes
Source provenance: Browse the complete Orange Book source catalog · source snapshot 42 .
Orange Book products# Current product rows page 1 of 1 · 1 matching rows.
Application-product, Trade name, Ingredient table Application-product Trade name Ingredient Strength Dosage form / route TE codes RLD / RS Approval date N217684-001 VIGAFYDE VIGABATRIN 100MG/ML SOLUTION / ORAL RLD, RS 2024-06-17
Orange Book patents# Current patent rows page 1 of 1 · 3 matching rows.
Application-product, Patent, Expiration table Application-product Patent Expiration Use code Coverage / status Submission date N217684-001 12016857 2039-08-16 Drug product 2024-07-01 N217684-001 12290499 2042-10-17 Drug product 2025-05-13 N217684-001 12576054 2043-06-08 Drug product 2026-03-23
Observed Orange Book product history# Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.
Captured, Edition, Application-product table Captured Edition Application-product Trade name Strength Dosage form / route Product TE source text RLD / RS Approval date Source SHA-256 2026-08-18 06:07:40 2026-07 N217684-001 VIGAFYDE 100MG/ML SOLUTION / ORAL RLD, RS 2024-06-17 caaa826d4ba7…2026-02-19 14:30 UTC 2026-02 N217684-001 VIGAFYDE 100MG/ML SOLUTION / ORAL RLD, RS 2024-06-17 011fe1cb6892…2025-12-14 10:44 UTC · 2 captures of this ZIP 2025-12 N217684-001 VIGAFYDE 100MG/ML SOLUTION / ORAL RLD, RS 2024-06-17 31067a03dcf5…2025-08-23 18:47 UTC 2025-08 N217684-001 VIGAFYDE 100MG/ML SOLUTION / ORAL RLD, RS 2024-06-17 6a471c1ec25d…2025-03-22 03:13 UTC · 3 captures of this ZIP 2025-03 N217684-001 VIGAFYDE 100MG/ML SOLUTION / ORAL RLD, RS 2024-06-17 fd3edfee7708…2025-02-26 10:13 UTC · 3 captures of this ZIP 2025-02 N217684-001 VIGAFYDE 100MG/ML SOLUTION / ORAL RLD, RS 2024-06-17 b8a1b40f171c…2025-01-19 17:59 UTC · 7 captures of this ZIP 2025-01 N217684-001 VIGAFYDE 100MG/ML SOLUTION / ORAL RLD, RS 2024-06-17 03ed91905a0d…2024-12-13 21:23 UTC · 2 captures of this ZIP 2024-12 N217684-001 VIGAFYDE 100MG/ML SOLUTION / ORAL RLD, RS 2024-06-17 2680178bc6a6…2024-09-14 05:58 UTC · 2 captures of this ZIP 2024-09 N217684-001 VIGAFYDE 100MG/ML SOLUTION / ORAL RLD, RS 2024-06-17 5bbf6a4d5a75…2024-11-08 22:44 UTC · 3 captures of this ZIP 2024-11 N217684-001 VIGAFYDE 100MG/ML SOLUTION / ORAL RLD, RS 2024-06-17 d8e5a09893c0…2024-10-29 15:01 UTC 2024-10 N217684-001 VIGAFYDE 100MG/ML SOLUTION / ORAL RLD, RS 2024-06-17 d06236e962d9…2024-08-13 05:28 UTC · 3 captures of this ZIP 2024-08 N217684-001 VIGAFYDE 100MG/ML SOLUTION / ORAL RLD, RS 2024-06-17 79d66fd596c7…2024-07-13 05:37 UTC · 2 captures of this ZIP 2024-07 N217684-001 VIGAFYDE 100MG/ML SOLUTION / ORAL RLD, RS 2024-06-17 301d65b070ca…2026-07-26 02:55 UTC · 3 captures of this ZIP 2026-06 N217684-001 VIGAFYDE 100MG/ML SOLUTION / ORAL RLD, RS 2024-06-17 a50c72e98297…
Observed Orange Book patent history# Captured, Edition, Application-product table Captured Edition Application-product Patent Expiration Use code Coverage / status Submission date Source SHA-256 2026-08-18 06:07:40 2026-07 N217684-001 12016857 2039-08-16 Drug product 2024-07-01 caaa826d4ba7…2026-08-18 06:07:40 2026-07 N217684-001 12290499 2042-10-17 Drug product 2025-05-13 caaa826d4ba7…2026-08-18 06:07:40 2026-07 N217684-001 12576054 2043-06-08 Drug product 2026-03-23 caaa826d4ba7…2026-02-19 14:30 UTC 2026-02 N217684-001 12016857 2039-08-16 Drug product 2024-07-01 011fe1cb6892…2026-02-19 14:30 UTC 2026-02 N217684-001 12290499 2042-10-17 Drug product 2025-05-13 011fe1cb6892…2025-12-14 10:44 UTC · 2 captures of this ZIP 2025-12 N217684-001 12016857 2039-08-16 Drug product 2024-07-01 31067a03dcf5…2025-12-14 10:44 UTC · 2 captures of this ZIP 2025-12 N217684-001 12290499 2042-10-17 Drug product 2025-05-13 31067a03dcf5…2025-08-23 18:47 UTC 2025-08 N217684-001 12016857 2039-08-16 Drug product 2024-07-01 6a471c1ec25d…2025-08-23 18:47 UTC 2025-08 N217684-001 12290499 2042-10-17 Drug product 2025-05-13 6a471c1ec25d…2025-03-22 03:13 UTC · 3 captures of this ZIP 2025-03 N217684-001 12016857 2039-08-16 Drug product 2024-07-01 fd3edfee7708…2025-02-26 10:13 UTC · 3 captures of this ZIP 2025-02 N217684-001 12016857 2039-08-16 Drug product 2024-07-01 b8a1b40f171c…2025-01-19 17:59 UTC · 7 captures of this ZIP 2025-01 N217684-001 12016857 2039-08-16 Drug product 2024-07-01 03ed91905a0d…2024-12-13 21:23 UTC · 2 captures of this ZIP 2024-12 N217684-001 12016857 2039-08-16 Drug product 2024-07-01 2680178bc6a6…2024-09-14 05:58 UTC · 2 captures of this ZIP 2024-09 N217684-001 12016857 2039-08-16 Drug product 2024-07-01 5bbf6a4d5a75…2024-11-08 22:44 UTC · 3 captures of this ZIP 2024-11 N217684-001 12016857 2039-08-16 Drug product 2024-07-01 d8e5a09893c0…2024-10-29 15:01 UTC 2024-10 N217684-001 12016857 2039-08-16 Drug product 2024-07-01 d06236e962d9…2024-08-13 05:28 UTC · 3 captures of this ZIP 2024-08 N217684-001 12016857 2039-08-16 Drug product 2024-07-01 79d66fd596c7…2024-07-13 05:37 UTC · 2 captures of this ZIP 2024-07 N217684-001 12016857 2039-08-16 Drug product 2024-07-01 301d65b070ca…2026-07-26 02:55 UTC · 3 captures of this ZIP 2026-06 N217684-001 12016857 2039-08-16 Drug product 2024-07-01 a50c72e98297…2026-07-26 02:55 UTC · 3 captures of this ZIP 2026-06 N217684-001 12290499 2042-10-17 Drug product 2025-05-13 a50c72e98297…2026-07-26 02:55 UTC · 3 captures of this ZIP 2026-06 N217684-001 12576054 2043-06-08 Drug product 2026-03-23 a50c72e98297…
openFDA label cross-check# OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
Matched openFDA labels page 1 of 1 · 1 matching rows.
Brand, Generic, Manufacturer table Brand Generic Manufacturer SPL set ID Effective date Available safety fields Join VIGAFYDE VIGABATRIN Upsher-Smith Laboratories, LLC 8d3d6316-33ab-41e8-9485-4495c218be56 2025-11-01 Boxed warning, Warnings, Adverse reactions Exact identifier application applno (NDA): 217684 application number: NDA217684
Documents# Document, Submission type, Date table Document Submission type Date 85616 SUPPL 2026-04-01 83293 SUPPL 2025-09-05 83292 SUPPL 2025-09-05 83291 SUPPL 2025-09-05 83280 SUPPL 2025-09-04 83279 SUPPL 2025-09-04 82202 ORIG 2025-05-19 79620 SUPPL 2024-09-16 78818 ORIG 2024-06-18 78817 ORIG 2024-06-18